MRI

Latest News


CME Content


MR-guided biopsies at 3T are showing great promise in prostate cancer because of their speed and high tumor detection rate in patients with rising PSA levels and previous negative biopsies, according to a leading research team from the Netherlands. They also do well in patients who have had previous radiotherapy sessions.

More is better and all but inevitable in medical imaging. In CT, more means slices. In MR, it’s channels for receiving radiofrequency signals. These currently number 32 on the most advanced commercially available systems. But a replacement for that benchmark is in the works.

Playing off the continuously moving table built into TimCT, Siemens Medical Solutions proclaimed “Tim (Siemens’ total image matrix) is on the move” at the International Society for Magnetic Resonance in Medicine meeting in Berlin. The company is featuring clinical results from its seven luminary installations of the technology in MR angiography and central nervous system imaging.

Volumetric and highly specialized imaging techniques will expand the clinical horizons of MR, according to GE Healthcare. Technologies that improve the speed of data acquisition and processing will make them practical.

Toshiba Medical Systems Europe is going toe-to-toe with the established high-end vendors at 1.5T during the International Society for Magnetic Resonance in Medicine meeting in Berlin. Its high-performance Vantage Atlas MR, shown several months earlier at the RSNA meeting as a work-in-progress, became a commercial reality with the first system installed and operating in March at a hospital in a Paris suburb and another more recently at an outpatient facility in Las Vegas.

Within two weeks this month, Berlin will have played host to two major and one very small radiological meeting. The German Roentgen Society has just left Berlin’s International Congress Center, and the combined International Society for Magnetic Resonance in Medicine (ISMRM)/European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) is gathering. At the end of this week, the 25th anniversary meeting of the European Magnetic Resonance Forum (EMRF) will take place at Cecilienhof Castle in Potsdam, some 20 km away.

Unlike tests that provide thresholds such as good or bad cholesterol levels, MR scans are open to interpretation. Early steps toward quantitation have focused on measuring tumor size and volume as indicators of cancer progression or patient response to therapy. Philips is going further.

No topic can dominate a conference as dynamic as the annual meeting of the International Society for Magnetic Resonance in Medicine. But with many experts chiming in on nephrogenic systemic fibrosis, the subject will be a focus of the society’s jointly sponsored conference with the European Society for Magnetic Resonance in Medicine and Biology starting Monday in Berlin.

A review of the current literature reveals a difference of opinion regarding whether to screen diabetic patients with CT and an inherent flaw with hybrid SPECT/CT scanners resulting in misregistered images. Researchers also optimized a contrast protocol for the triple rule-out procedure and advise echo studies when mitral valve calcification is found on chest CT.

Most orthopedic implants are made from nonferromagnetic materials and, therefore, tend to be acceptable for patients undergoing MRI examinations. In vitro testing conducted at 1.5T and 3T has verified the safe aspects of orthopedic devices with regard to magnetic field interactions (see www.MRIsafety.com for a summary of this information).

Most U.S. breast specialists are performing contrast-enhanced breast MRI, albeit at a fairly low volume, according to a survey presented today at the American Roentgen Ray Society meeting in Orlando. About one-third of facilities performing breast MRI do not offer MRI-guided biopsies as well, however.